Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Critical Reviews in Oncology/Hematology|December 30, 2015
Tailoring the dosing schedule of nab-paclitaxel in metastatic breast cancer according to patient and disease characteristics: Recommendations from a panel of expertsG Arpino, F Marmé, J Cortés, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 27, 2015
High pKDR immunohistochemical expression is an unfavourable prognostic biomarker in patients with advanced colorectal cancer treated with chemotherapy plus bevacizumabJ Garde-Noguera, M Gil-Raga, E Evgenyeva, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 24, 2013
SEOM clinical guidelines for the management of metastatic breast cancer 2013A Llombart Cussac, J de la Haba Rodríguez, A Ruiz Simón, et al.
Breast Cancer Research and Treatment|October 29, 2005
Improvement of breast cancer relapse prediction in high risk intervals using artificial neural networksJ M Jerez, L Franco, E Alba, et al.
Oncology|September 10, 1998
First-line vinorelbine-mitoxantrone combination in metastatic breast cancer patients relapsing after an adjuvant anthracycline regimen: results of a phase II studyA Llombart-Cussac, X Pivot, A Rhor-Alvarado, et al.
British Journal of Cancer|December 23, 1998
Adjuvant chemotherapy for primary cardiac sarcomas: the IGR experienceA Llombart-Cussac, X Pivot, G Contesso, et al.
European Journal of Cancer (Oxford, England : 1990)|January 30, 2004
The poor responsiveness of infiltrating lobular breast carcinomas to neoadjuvant chemotherapy can be explained by their biological profileM-C Mathieu, R Rouzier, A Llombart-Cussac, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 28, 2006
The "El Alamo" project (1990-1997): two consecutive hospital-based studies of breast cancer outcomes in SpainM Martín, E Mahillo, A Llombart-Cussac, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 16, 2006
Biweekly gemcitabine plus vinorelbine in first-line metastatic breast cancer: efficacy and correlation with HER2 extracellular domainR Colomer, A Llombart-Cussac, I Tusquets, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 7, 2010
Efficacy of zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: 36-month results of the ZO-FAST StudyH Eidtmann, R de Boer, N Bundred, et al.
Pageof 4